Ectycell Folded into Cellectis bioresearch | GenomeWeb

NEW YORK (GenomeWeb News) – Cellectis Group today announced that its stem cell business unit Ectycell has merged with Cellectis bioresearch.

Cellectis Group also announced a €3.5 million ($4.1 million) capital increase into Cellectis bioresearch, which was subscribed for by French financial organization Caisse des Depots.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.